Rapid, portable detection of multiple nucleic acid targets is essential for infectious disease surveillance and precision oncology. CRISPR-based diagnostics have set a high bar for sensitivity and single-base specificity, yet their reliance on collateral nuclease activity complicates multiplexing, integration with amplification, and point-of-care deployment. Here, we present TIMBER (templated incision mediated by endonucleases of repair), a non-CRISPR platform that achieves comparable performance without nonspecific nuclease activity. TIMBER uses a repair endonuclease to cleave probes containing abasic sites only when they are hybridized to a matched target. The system exhibits strong specificity, enabling single-nucleotide polymorphism discrimination. TIMBER provides an analytical limit of detection of 12 pM without preamplification or one copy per μL (1.6 aM) with preamplification through RT-PCR or RT-LAMP, with results observable by visual fluorescence or on lateral flow. We deploy TIMBER to detect SARS-CoV-2 in clinical saliva samples and further demonstrate multiplex detection of four targets, enabling identification of EGFR mutations in lung cancer samples. This approach offers a flexible, rapid, and low-instrument-ready solution for diverse nucleic acid diagnostics, from viral detection to cancer genotyping.
No takes yet. Share an insight, caveat, or question.
Garden et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: